TBX1 and chordoma: Although the validity of the experiments has limitations due to treatment-related adversities (e.g., high baseline toxicity in the very sensitive chordoma cells or time-dependent reduction in the expression of the transfected TBXT-ORF vector), it can be assumed that brachyury level reduction after dinaciclib treatment may not be the sole factor for the detected viability reduction.